Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Guidelines published on long-term use of NSAIDs in cats
The first version of the consensus guidelines was published in 2010.
ISFM and AAFP release new version of their consensus guidelines.

An updated consensus guidelines for the long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) in cats with chronic pain has been published.

Created by the International Society of Feline Medicine (ISFM) and the American Association of Feline Practitioners (AAFP), the guidelines are designed to support veterinary surgeons with making decisions about prescribing NSAIDs long-term to optimise pain management and minimise adverse effects.

The guidelines include information on assessing patient suitability, considerations to take into account when there are comorbidities present, and how to monitor treatment efficacy.

Alongside the guidelines, the ISFM has created three new guides for owners whose cats have been prescribed NSAIDs: ‘Treating chronic (long-lasting) pain with NSAIDs’, ‘Changes to the home environment for cats with muscle/joint pain or mobility problems’ and ‘Encouraging your cat to drink’. AAFP has also produced a client brochure: ‘Treating chronic pain with NSAIDs’, which goes alongside the guidelines.

ISFM and AAFP published the first version of their NSAID guidelines in 2010. The latest version has been informed by multiple studies into the use of NSAIDs in cats, many with a focus on cats with comorbidities, which have been published since then.

Heather O’Steen, AAFP chief executive, said: “We are thrilled to announce the release of these new guidelines addressing long-term use of NSAIDs in cats.

With a focus on safety, efficacy, and responsible medication management, these guidelines aim to enhance the quality of life for cats while minimising potential risks. We believe that these guidelines will serve as a vital resource in ensuring the optimal care and wellbeing of cats receiving long-term NSAID therapy.”

The ‘2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats’ has been published in the Journal of Feline Medicine and Surgery.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.